Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study is designed to understand the pharmacokinetics of different oral formulations of
CK-1827452 being considered for future studies in patients with heart failure. This study
will compare the pharmacokinetics and safety and tolerability of both modified-release (MR)
and immediate-release (IR) oral formulations of CK-1827452.